Tumor Heterogeneity and Consequences for Bladder Cancer Treatment
Acquired therapeutic resistance remains a major challenge in cancer management and associates with poor oncological outcomes in most solid tumor types. A major contributor is tumor heterogeneity (TH) which can be influenced by the stromal; immune and epithelial tumor compartments. We hypothesize tha...
Guardado en:
Autores principales: | Etienne Lavallee, John P. Sfakianos, David J. Mulholland |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72c5d52292834519b11dd8987ebe4ef7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
por: Sharanya Maanasi Kalasekar, et al.
Publicado: (2021) -
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients
por: Gedmante Radziuviene, et al.
Publicado: (2021) -
Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
por: Kostas Palamaris, et al.
Publicado: (2021) -
Mammographic density parameters and breast cancer tumor characteristics among postmenopausal women
por: Velásquez García HA, et al.
Publicado: (2019) -
Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders
por: Ian J. Cooke, et al.
Publicado: (2021)